Invention Grant
US08486918B2 Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor
失效
苯基恶二唑衍生物作为1-磷酸鞘氨醇（S1P）受体
- Patent Title: Phenyl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor
- Patent Title (中): 苯基恶二唑衍生物作为1-磷酸鞘氨醇（S1P）受体
-
Application No.: US13295324Application Date: 2011-11-14
-
Publication No.: US08486918B2Publication Date: 2013-07-16
- Inventor: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha Bin Im
- Applicant: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha Bin Im
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K31/4245 ; C07F9/653 ; C07D271/06
Abstract:
The present invention relates to novel phenyl oxadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20120142745A1 NOVEL PHENYL OXADIAZOLE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS Public/Granted day:2012-06-07
Information query
